Related Experiment Video
Updated: Jul 4, 2025

Measuring Single-Cell Mitochondrial DNA Copy Number and Heteroplasmy Using Digital Droplet Polymerase Chain Reaction
Published on: July 12, 2022
The role of mitochondrial DNA copy number in cardiometabolic disease: a bidirectional two-sample mendelian
Pei Qin1, Tianhang Qin2, Lei Liang3
1Department of General Practice, The Affiliated Luohu Hospital of Shenzhen University, No. 47, Youti Road, Shenzhen, 518001, Guangdong, China.
Insights
Mitochondrial DNA (mtDNA) copy number does not causally influence cardiometabolic diseases. However, dyslipidemia and coronary artery disease (CAD) may lead to reduced mtDNA copy number, suggesting its potential as a biomarker.
Area of Science:
- Genetics
- Cardiology
- Metabolic Health
Background:
- Mitochondrial DNA (mtDNA) copy number is implicated in cellular energy production.
- Cardiometabolic diseases encompass a range of conditions including obesity, diabetes, and cardiovascular disorders.
- The causal relationship between mtDNA copy number and cardiometabolic diseases remains unclear.
Purpose of the Study:
- To investigate the potential causal effect of mtDNA copy number on cardiometabolic diseases using a bidirectional Mendelian randomization approach.
- To explore the reverse causation, examining if cardiometabolic diseases influence mtDNA copy number.
Main Methods:
- A bidirectional 2-sample Mendelian randomization study was employed.
- Genome-wide association study (GWAS) summary statistics from UK Biobank (n=395,718) were utilized for genetic instruments.
- Inverse variance weighting (IVW) was the primary analysis, with MR-Egger, weighted median, and MR-PRESSO as sensitivity analyses.
Main Results:
- Genetically predicted mtDNA copy number showed no significant causal association with obesity, hypertension, dyslipidemia, type 2 diabetes (T2DM), coronary artery disease (CAD), stroke, ischemic stroke, or heart failure.
- In reverse analyses, genetically predicted dyslipidemia was significantly associated with decreased mtDNA copy number (P=2.416e-14).
- Suggestive evidence indicated a potential causal association between CAD and reduced mtDNA copy number (P=0.025).
Conclusions:
- This study does not support a causal role for mtDNA copy number in the development of cardiometabolic diseases.
- Dyslipidemia and CAD may causally lead to a reduction in mtDNA copy number.
- mtDNA copy number may serve as a potential biomarker for dyslipidemia and CAD.
Background:
This study used a bidirectional 2-sample Mendelian randomization study to investigate the potential causal links between mtDNA copy number and cardiometabolic disease (obesity, hypertension, hyperlipidaemia, type 2 diabetes [T2DM], coronary artery disease [CAD], stroke, ischemic stroke, and heart failure).
Methods:
Genetic associations with mtDNA copy number were obtained from a genome-wide association study (GWAS) summary statistics from the UK biobank (n = 395,718) and cardio-metabolic disease were from largest available GWAS summary statistics. Inverse variance weighting (IVW) was conducted, with weighted median, MR-Egger, and MR-PRESSO as sensitivity analyses. We repeated this in the opposite direction using instruments for cardio-metabolic disease.
Results:
Genetically predicted mtDNA copy number was not associated with risk of obesity (P = 0.148), hypertension (P = 0.515), dyslipidemia (P = 0.684), T2DM (P = 0.631), CAD (P = 0.199), stroke (P = 0.314), ischemic stroke (P = 0.633), and heart failure (P = 0.708). Regarding the reverse directions, we only found that genetically predicted dyslipidemia was associated with decreased levels of mtDNA copy number in the IVW analysis (β= - 0.060, 95% CI - 0.044 to - 0.076; P = 2.416e-14) and there was suggestive of evidence for a potential causal association between CAD and mtDNA copy number (β= - 0.021, 95% CI - 0.003 to - 0.039; P = 0.025). Sensitivity and replication analyses showed the stable findings.
Conclusions:
Findings of this Mendelian randomization study did not support a causal effect of mtDNA copy number in the development of cardiometabolic disease, but found dyslipidemia and CAD can lead to reduced mtDNA copy number. These findings have implications for mtDNA copy number as a biomarker of dyslipidemia and CAD in clinical practice.
Related Concept Videos
Animal Mitochondrial Genetics
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Mitochondria
Mitochondrial Membranes
Genome Copying Errors
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

